[go: up one dir, main page]

ATE231160T1 - Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel - Google Patents

Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel

Info

Publication number
ATE231160T1
ATE231160T1 AT00400286T AT00400286T ATE231160T1 AT E231160 T1 ATE231160 T1 AT E231160T1 AT 00400286 T AT00400286 T AT 00400286T AT 00400286 T AT00400286 T AT 00400286T AT E231160 T1 ATE231160 T1 AT E231160T1
Authority
AT
Austria
Prior art keywords
erythromycin derivatives
production
medicinal products
halo
formula
Prior art date
Application number
AT00400286T
Other languages
English (en)
Inventor
Alexis Denis
Claude Fromentin
Bertrand Heckmann
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE231160T1 publication Critical patent/ATE231160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00400286T 1999-02-04 2000-02-03 Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel ATE231160T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901292A FR2789392B1 (fr) 1999-02-04 1999-02-04 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ATE231160T1 true ATE231160T1 (de) 2003-02-15

Family

ID=9541593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00400286T ATE231160T1 (de) 1999-02-04 2000-02-03 Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel

Country Status (8)

Country Link
US (1) US6313101B1 (de)
EP (1) EP1026170B1 (de)
JP (2) JP5019665B2 (de)
AT (1) ATE231160T1 (de)
DE (1) DE60001182T2 (de)
DK (1) DK1026170T3 (de)
ES (1) ES2186615T3 (de)
FR (1) FR2789392B1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
DE69913738T2 (de) * 1999-01-27 2004-06-17 Pfizer Products Inc., Groton Ketolid-antibiotika
AU3832100A (en) * 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
DK1167376T3 (da) 2000-06-30 2004-10-25 Pfizer Prod Inc Makrolidantibiotika
RU2397987C2 (ru) * 2004-07-28 2010-08-27 Рэнбакси Лабораториз Лимитед Кетолидные производные в качестве антибактериальных агентов
EP1807439A2 (de) * 2004-10-25 2007-07-18 Ranbaxy Laboratories Limited Ketolid-derivate als antibakterielle agentien
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
AU2009308180B2 (en) 2008-10-24 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
EP2613630A4 (de) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Wasserstoffbindung zur formung von fluorketoliden zur behandlung von krankheiten
EP2830632A4 (de) 2012-03-27 2015-10-21 Cempra Pharmaceuticals Inc Parenterale formulierungen zur verabreichung von makrolid-antibiotika
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
CN104860943B (zh) * 2015-05-18 2017-11-17 上海毕路得医药科技有限公司 5,7‑二氯‑1h‑咪唑并[4,5‑b]吡啶的合成方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
JP5222348B2 (ja) 2013-06-26
DK1026170T3 (da) 2003-05-05
DE60001182D1 (de) 2003-02-20
DE60001182T2 (de) 2003-10-09
FR2789392A1 (fr) 2000-08-11
JP2000229993A (ja) 2000-08-22
JP2011136990A (ja) 2011-07-14
EP1026170B1 (de) 2003-01-15
JP5019665B2 (ja) 2012-09-05
FR2789392B1 (fr) 2001-10-05
US6313101B1 (en) 2001-11-06
EP1026170A1 (de) 2000-08-09
ES2186615T3 (es) 2003-05-16

Similar Documents

Publication Publication Date Title
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
LU91761I2 (fr) Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®)
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
CA2379026A1 (en) Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
IL123776A0 (en) Novel derivatives of cyclodepsipeptide PF 1022
PT992509E (pt) Novos derivados macrolidos
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
WO2001090102A3 (de) 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline
ATE521619T1 (de) Neue erythromycin-derivate, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
FR2787109B1 (fr) Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE123034T1 (de) Cephalosporinzwischenverbindungen, verfahren zu ihrer herstellung sowie zur herstellung ihrer endprodukte.
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
ATE211136T1 (de) Coumarin-derivate, verfahren zu deren herstellung und deren verwendung
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
DK305184D0 (da) Hexahydropyrrolo(2,1-a)isoquinolin-derivater
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE279434T1 (de) Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
ATE171450T1 (de) Thiazolidin-2,4-dion-derivate, salze hiervon sowie verfahren zur herstellung
ATE229495T1 (de) Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen
DE60102113D1 (de) Ammonium-3,5,6-trihydroxyhexansäure-Derivate und Methoden zu ihrer Herstellung
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
DE50000575D1 (de) Verfahren zur Herstellung von Folsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1026170

Country of ref document: EP

REN Ceased due to non-payment of the annual fee